Europe

Mead makes his way to Mobeus
Matthew Mead has resurfaced at Mobeus Equity Partners as a venture partner ten months after stepping down as chief investment officer of Mercia Technologies.
Strathclyde books in Listings Ledger
Listings Ledger has spun out from the university to commercialise a real-time valuation ticker for privately-owned companies.
Centrica gives Mixergy a whirl
The energy supplier's corporate venturing subsidiary has put an undisclosed sum into Oxford's smart water boiler spinout Mixergy.
Liverpool universities grasp Sciontec
University of Liverpool, Liverpool John Moores and Liverpool City Council will launch the Sciontec Liverpool fund to drive works for the city’s $2.6bn Knowledge Quarter Liverpool project.
NetScientific to delist from Aim
Commercialisation firm NetScientific will delist from Aim to free up cash for its portfolio companies, having failed to attract concrete offers after putting itself up for an acquisition.
OssDsign takes in $6.9m
Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.
Van Nevel vaults over to Qbic
Cédric Van Nevel has departed Bekaert to become an investment manager at Qbic, a venture fund manager focused on spinouts of Ghent, Brussels and Antwerp universities and of Vito.
Karolinska Development portfolio value gains one third
The gains came against a backdrop of falling net profits and cash reserves that will test Karolinska Development as it looks ahead to convertible debt obligations.

Other News

Insignals flexes its muscles
Spun out of Inesc Tec under a strategic agreement with Frontier IP, Insignals hopes to commercialise a surgical guidance device for brain implants to treat conditions including Parkinson's.
CIC stays Pragmatic in $17m round
The flexible electronics maker once known as Pragmatic Printing has retained the interest of CIC, Avery Dennison and Arm to take its total funding to nearly $47m.
C-Capture catches $4.6m
IP Group returned to join corporates BP and Drax for the Leeds CO2 capture spinout’s latest round, taking its total investment in the company to $2.2m since 2009.
HTGF adds flavour to 4Gene’s seed round
4Gene is advancing TUM research into exploiting plant-derived glucosides as flexible triggers for releasing flavouring and aromas.
Marinomed hits Vienna Stock Exchange
VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.
Blue Water seeks $15m injection
US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Opportunities and challenges abound at PraxisAuril conference
PraxisAuril's spring conference continues to go from strength to strength, with one in three delegates a first-time attendant.
test reg

Login